Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Five More Biopharmas Enter US Queue Even As IPO Returns Dip

Aug 23 2019

• By Mandy Jackson

Finance Watch

Related Content

Protalix/Pfizer first in US with plant cell-based recombinant therapeutic protein

May 02 2012

Monopar Therapeutics LLC

Sep 24 2015

Finance Watch: A One-Time Treatment For Heart Disease? Verve Raises $58.5m To Give It A Try

May 07 2019

Finance Watch: BIO Report Shows Record VC Funding Across Geographies

Jun 04 2019

Finance Watch: Arteaus Comes Full Circle As Investors Monetize Emgality Royalties

Apr 01 2019

Finance Watch: Among Multiple Mega-Rounds, Revolution Raises $100m For RAS Programs

Jul 12 2019

Deal Watch: Are Ultragenyx, REGENXBIO In A Bidding War For Dimension?

Sep 26 2017

Garland Takes Helm Of Portola At A Crucial Time

Sep 20 2018

CAR-T Forecast: Celgene Follows, But Also Leads As Next Batch Of T-Cell Therapies Near Market

Jan 04 2019

IPO Update: 28 Biopharma Companies Raise $3bn, Provide An Average 10% Return

Jun 28 2019

Related Companies

Turning Point Therapeutics Inc.

Anchiano Therapeutics Ltd.

TFF Pharmaceuticals, Inc.

IGM Biosciences, Inc.

Pfizer Inc.

SpringWorks Therapeutics Inc.

Satsuma Pharmaceuticals, Inc.

Monopar Therapeutics Inc.

Valerio Therapeutics

Deciphera Pharmaceuticals, Inc.

Portola Pharmaceuticals, Inc.

Bellicum Pharmaceuticals, Inc.

Protalix BioTherapeutics, Inc.

Chiesi Farmaceutici S.p.A.

Additional Topics

Financing Strategy Deals Business Strategies Commercial BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window